| Financial Year |
March 31 2023 |
| Monetary Funds |
2,763,966,316.63 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
227,128,143.57 |
| Accounts Receivable |
890,990,673.67 |
| Advances to Suppliers |
1,280,268,372.71 |
| Other Receivables |
157,852,635.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
10,000,000.00 |
| Inventories |
180,131,006.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
334,882,758.69 |
| Other Current Assets |
90,483,494.23 |
| Total Current Assets |
8,379,916,299.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
389,041,121.54 |
| Long-term Equity Investment |
528,566,028.81 |
| Investment Properties |
-- |
| Fixed Assetes |
472,712,723.77 |
| Under-construction Projects |
571,757,372.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
368,788,099.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,929,559.71 |
| Deferred Income Tax Assets |
115,675,068.93 |
| Other Non-Current Assets |
950,645,910.79 |
| Sub-Total of Non-Current Assets |
3,545,040,695.77 |
| Total Assets |
11,924,956,994.99 |
| Short-Term Loans |
60,056,666.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,199,198.80 |
| Accounts Payable |
4,251,867,114.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,612,496.43 |
| Taxes Payable |
167,900,272.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
116,014,281.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,570,155.01 |
| Other Current Liabilities |
341,325,702.17 |
| Sub-Total of Current Liabilities |
6,607,187,648.69 |
| Long-term Loans |
1,198,045,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
77,411,600.00 |
| Deferred Income Tax Liabilities |
8,557,018.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,299,795,402.36 |
| Total Liabilities |
7,906,983,051.05 |
| Paid-In Capital(Or Share Stock) |
708,182,622.00 |
| Capital Surplus |
874,242,729.09 |
| Surplus Reserve |
310,094,008.59 |
| LESS:Treasury Stock |
17,424,525.00 |
| Undistributed Profits |
1,898,362,352.98 |
| Minority Stockholder's Interest |
236,529,775.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,781,444,168.67 |
| Owner's Equity（Stockholder's Equity） |
4,017,973,943.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,924,956,994.99 |
